Search research articles
Contact Us
Filters
Showing results (41-50 of 92) with videos related to
Page
of 10
Sort By:
Research and Practice in Thrombosis and Haemostasis
|
December 10, 2025
Evaluation of kidney function and damage in patients with hemophilia B-insights from the B-Natural study
Jan Astermark, Petra LeBeau, Anders Christensson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 9, 2021
Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A
Jan Astermark, Anna Olsson, Pierre Chelle, et al.
Therapeutic Advances in Hematology
|
April 28, 2023
Considerations for shared decision management in previously untreated patients with hemophilia A or B
Jan Astermark, Jan Blatný, Christoph Königs, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 11, 2021
rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B-LONG using haemophilia-specific quality of life questionnaires
Jan Astermark, Cédric Hermans, Monia Ezzalfani, et al.
Blood
|
August 24, 2006
Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A
Jan Astermark, Johannes Oldenburg, Joyce Carlson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 15, 2019
Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years
Mehdi Osooli, Sharyne M Donfield, Katarina Steen Carlsson, et al.
Therapeutic Advances in Hematology
|
June 7, 2023
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B:
Jan Astermark, Cédric Hermans, Monia Ezzalfani, et al.
Blood
|
September 23, 2006
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study
Jan Astermark, Sharyne M Donfield, Donna M DiMichele, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 29, 2019
Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis
Olav Versloot, Erik Berntorp, Pia Petrini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 17, 2021
Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?
Katharina Holstein, Sandra Le Quellec, Robert Klamroth, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 92) with videos related to
Sort By:
Page
of 10
Research and Practice in Thrombosis and Haemostasis
|
December 10, 2025
Evaluation of kidney function and damage in patients with hemophilia B-insights from the B-Natural study
Jan Astermark, Petra LeBeau, Anders Christensson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 9, 2021
Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A
Jan Astermark, Anna Olsson, Pierre Chelle, et al.
Therapeutic Advances in Hematology
|
April 28, 2023
Considerations for shared decision management in previously untreated patients with hemophilia A or B
Jan Astermark, Jan Blatný, Christoph Königs, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 11, 2021
rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B-LONG using haemophilia-specific quality of life questionnaires
Jan Astermark, Cédric Hermans, Monia Ezzalfani, et al.
Blood
|
August 24, 2006
Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A
Jan Astermark, Johannes Oldenburg, Joyce Carlson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 15, 2019
Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years
Mehdi Osooli, Sharyne M Donfield, Katarina Steen Carlsson, et al.
Therapeutic Advances in Hematology
|
June 7, 2023
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B:
Jan Astermark, Cédric Hermans, Monia Ezzalfani, et al.
Blood
|
September 23, 2006
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study
Jan Astermark, Sharyne M Donfield, Donna M DiMichele, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 29, 2019
Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis
Olav Versloot, Erik Berntorp, Pia Petrini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 17, 2021
Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?
Katharina Holstein, Sandra Le Quellec, Robert Klamroth, et al.
Page
of 10